What combines best with GLP-1 for obesity treatment: GIP receptor agonists or antagonists?

Research output: Contribution to journal › Comment/debate › Research

Standard

What combines best with GLP-1 for obesity treatment : GIP receptor agonists or antagonists? / Holst, Jens Juul.

In: Cell Reports Medicine, Vol. 2, No. 5, 100284, 2021.

Research output: Contribution to journal › Comment/debate › Research

Harvard

Holst, JJ 2021, 'What combines best with GLP-1 for obesity treatment: GIP receptor agonists or antagonists?', Cell Reports Medicine, vol. 2, no. 5, 100284. https://doi.org/10.1016/j.xcrm.2021.100284

APA

Holst, J. J. (2021). What combines best with GLP-1 for obesity treatment: GIP receptor agonists or antagonists? Cell Reports Medicine, 2(5), [100284]. https://doi.org/10.1016/j.xcrm.2021.100284

Vancouver

Holst JJ. What combines best with GLP-1 for obesity treatment: GIP receptor agonists or antagonists? Cell Reports Medicine. 2021;2(5). 100284. https://doi.org/10.1016/j.xcrm.2021.100284

Author

Holst, Jens Juul. / What combines best with GLP-1 for obesity treatment : GIP receptor agonists or antagonists?. In: Cell Reports Medicine. 2021 ; Vol. 2, No. 5.

Bibtex

@article{8a47308723084c0fb81236fcfb3432db,
title = "What combines best with GLP-1 for obesity treatment: GIP receptor agonists or antagonists?",
abstract = "Lu et al.1 previously demonstrated that antagonist antibodies against the GIP receptor promote weight loss combined with GLP-1. They now elegantly developed a conjugate of GIPR antibodies and GLP-1 and show effective weight loss in obese non-human primates.",
author = "Holst, {Jens Juul}",
year = "2021",
doi = "10.1016/j.xcrm.2021.100284",
language = "English",
volume = "2",
journal = "Cell Reports Medicine",
issn = "2666-3791",
publisher = "Cell Press",
number = "5",

}

RIS

TY - JOUR

T1 - What combines best with GLP-1 for obesity treatment

T2 - GIP receptor agonists or antagonists?

AU - Holst, Jens Juul

PY - 2021

Y1 - 2021

N2 - Lu et al.1 previously demonstrated that antagonist antibodies against the GIP receptor promote weight loss combined with GLP-1. They now elegantly developed a conjugate of GIPR antibodies and GLP-1 and show effective weight loss in obese non-human primates.

AB - Lu et al.1 previously demonstrated that antagonist antibodies against the GIP receptor promote weight loss combined with GLP-1. They now elegantly developed a conjugate of GIPR antibodies and GLP-1 and show effective weight loss in obese non-human primates.

U2 - 10.1016/j.xcrm.2021.100284

DO - 10.1016/j.xcrm.2021.100284

M3 - Comment/debate

C2 - 34095885

AN - SCOPUS:85106325129

VL - 2

JO - Cell Reports Medicine

JF - Cell Reports Medicine

SN - 2666-3791

IS - 5

M1 - 100284

ER -

ID: 272176361